Key Stats for CVS Health Stock
- Price change for CVS Health stock in last 6 months: -27%
- $CVS Stock Price as of Aug. 5: $99
- 52-Week High: $111
- $CVS Stock Price Target: $115
Now Live: Discover how much upside your favorite stocks could have using TIKR’s new Valuation Model (It’s free)>>>
What Happened?
CVS Health (CVS) reported Q2 earnings of $2.58 per share, well above the $1.85 analysts had expected. Revenue came in at $106.1 billion, up 7.3% from a year ago and ahead of the $100.09 billion Wall Street was looking for. Adjusted operating income jumped 35.5% to $5.15 billion.
The company’s health services unit, which includes its clinics, saw operating profit rise 10% to $1.73 billion from $1.58 billion. That growth was driven by changes to how CVS runs its Oak Street primary care business.
CVS also announced a new offering aimed at the booming weight-loss drug market. MinuteClinic will now provide $29 appointments for adults seeking prescriptions for GLP-1 drugs like Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.
That’s a notable price point in a category where cost has been a major barrier for many patients.
On top of the earnings beat, CVS Health raised its full-year 2026 guidance. The company now expects adjusted earnings per share between $7.90 and $8.10, up from its prior range of $7.30 to $7.50.
That new range also sits above the $7.45 that analysts had been forecasting.
See analysts’ growth forecasts and price targets for CVS Health stock (It’s free) >>>
What the Market Is Telling Us About CVS Health Stock
The early jump in CVS Health stock shows investors initially liked what they saw. A big earnings beat, a strong revenue number, and a meaningfully higher guidance range are usually all good signs.
But the fact that CVS Health stock has cooled off from its premarket highs suggests some investors are taking a more measured view.
That kind of pattern isn’t unusual after a big guidance raise. Sometimes the market’s first reaction is enthusiasm, but as the day goes on, investors start asking harder questions.
With CVS Health, the company beat expectations across nearly every major number this quarter, from earnings to revenue to operating income.
The new $29 weight-loss drug pricing also shows CVS is trying to get ahead of a fast-growing and competitive market.
Even so, a strong quarter and higher guidance don’t always translate into a stock holding its gains. For now, CVS Health stock reflects a market that’s still processing a genuinely strong report, even if the initial excitement has faded somewhat as the session wears on.
Estimate a company’s fair value instantly (Free with TIKR) >>>
How Much Upside Does CVS Health Stock Have From Here?
With TIKR’s new Valuation Model tool, you can estimate a stock’s potential share price in under a minute.
All it takes is three simple inputs:
- Revenue Growth
- Operating Margins
- Exit P/E Multiple
If you’re not sure what to enter, TIKR automatically fills in each input using analysts’ consensus estimates, giving you a quick, reliable starting point.
From there, TIKR calculates the potential share price and total returns under Bull, Base, and Bear scenarios so you can quickly see whether a stock looks undervalued or overvalued.
See a stock’s true value in under 60 seconds (Free with TIKR) >>>
Looking for New Opportunities?
- See what stocks billionaire investors are buying so you can follow the smart money.
- Analyze stocks in as little as 5 minutes with TIKR’s all-in-one, easy-to-use platform.
- The more rocks you overturn… the more opportunities you’ll uncover. Search 100K+ global stocks, global top investor holdings, and more with TIKR.
Disclaimer:
Please note that the articles on TIKR are not intended to serve as investment or financial advice from TIKR or our content team, nor are they recommendations to buy or sell any stocks. We create our content based on TIKR Terminal’s investment data and analysts’ estimates. Our analysis might not include recent company news or important updates. TIKR has no position in any stocks mentioned. Thank you for reading, and happy investing!
